Litcius/Paper detail

Combination of AURKA inhibitor and HSP90 inhibitor to treat breast cancer with AURKA overexpression and TP53 mutations

Fuping Wang, Haotian Zhang, Haitao Wang, Tian Qiu, Binghong He, Qiong Yang

2022Medical Oncology20 citationsDOI

Topics & Concepts

Cancer researchBreast cancerHsp90 inhibitorCancerBiologyHsp90Cancer cellMedicineInternal medicineHeat shock proteinGeneticsGeneMicrotubule and mitosis dynamicsCancer-related Molecular PathwaysDNA Repair Mechanisms
Combination of AURKA inhibitor and HSP90 inhibitor to treat breast cancer with AURKA overexpression and TP53 mutations | Litcius